Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AbbVie

Baxter

BeiGene

Centene

Exact Sciences

GE HealthCare Technologies Inc

IDEXX Laboratories

Neurocrine Biosciences

Pfizer

After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022.

5 Best and Worst Performing Healthcare Stocks in January 2023

But should they be? After a sour 2022, the stock market has been sweet so far this year for shareholders of beaten down stocks. There is perhaps no better example than Align Technology.

Align Technology Shareholders Are All Smiles Now

Medical device company Align Technology Inc. ALGN, -4.66% said Monday it has entered a $250 million accelerated share repurchase agreement with Citibank N.A. under the $1.0 billion stock buyback program announced on May 13, 2021.

Align Technology in $250 million accelerated share repurchase agreement with Citibank

The stock shot up around 26% after reporting fourth-quarter results that were much better than expected.

Is Align Technology a Buy After Exceeding Expectations?

Investors breathed sighs of relief as the dental device maker's sales stabilized.

Why Align Technology Stock Soared Today

Align Technologies Inc. shares rallied Thursday, making one of the worst stocks of 2022 one of the best in 2023 so far.

Align Tech stock surges 30% to lead S&P 500 as Invisalign sales return to growth

Align Technology painted a "rosy vision" for 2023, an analyst said Thursday as ALGN stock launched to its highest point since April. The post Invisalign Maker Align Tech Catapults 27% On Its 'Rosy Vision' For 2023 appeared first on Investor's Business Daily.

Invisalign Maker Align Tech Catapults 27% On Its 'Rosy Vision' For 2023

Why Meta and Align Are Sending the Nasdaq Soaring Thursday

Align Technology's (ALGN) lower scanner volume and ASPs are partially offset by higher services revenues from the larger installed base of scanners and increased non-system revenues.

Align Technology (ALGN) Q4 Earnings Top Estimates, Margins Drop

Align Technology, Inc. (NASDAQ:ALGN ) Q4 2022 Earnings Conference Call February 1, 2023 4:30 PM ET Company Participants Shirley Stacy - VP, Corporate Communications & IR Joseph Hogan - President, CEO & Director John Morici - CFO & EVP, Global Finance Conference Call Participants Jason Bednar - Piper Sandler & Co. Jeffrey Johnson - Robert W. Baird & Co. Elizabeth Anderson - Evercore ISI Jonathan Block - Stifel, Nicolaus & Company Brandon Vazquez - William Blair & Company Erin Wright - Morgan Stanley Michael Ryskin - Bank of America Merrill Lynch Nathan Rich - Goldman Sachs Group Kevin Caliendo - UBS Operator Greetings, welcome to the Align Fourth Quarter and 2022 Earnings Call.

Align Technology, Inc. (ALGN) Q4 2022 Earnings Call Transcript

Align Technology (ALGN) delivered earnings and revenue surprises of 13.82% and 1.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Align Technology (ALGN) Q4 Earnings and Revenues Surpass Estimates

Align Technology Inc.  ALGN, +4.75% shares rallied in the extended session Wednesday after the maker of Invisalign braces reported results that topped Wall Street estimates. Align shares surged as much as 14% after hours, following a 4.8% rise to finish the session at $282.53.

Align Technologies stock surges more than 10% after earnings beat

Albemarle

NVIDIA

Tesla

Warner Bros Discovery Inc

According to the sector and industry overview pages, the five U.S. market sectors with the largest gains during January were consumer cyclical, communication services, technology, basic materials and health care. Stocks that fueled these gains included Tesla Inc. ( TSLA , Financial), Warner Bros.

5 Stocks Fueling US Market's Strong Start to 2023

TEMPE, Ariz.--( BUSINESS WIRE )--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the fourth quarter ("Q4'22") and year ended December 31, 2022 ("2022"). Q4'22 total revenues were $901.5 million, up 1.3% sequentially and down 12.6% year-over-year. Q4'22 Clear Aligner revenues were $731.7 million, flat sequentially and down 10.3% year-over-year. Q4'22 Clear Aligner volume was up 1.1% sequentially and down 7.5% year-over-year. Q4'22 Imaging Systems and CAD/CAM Services revenues were $169.9 million, up 7.8% sequentially and down 21.3% year-over-year. Q4'22 Clear Aligner revenues were unfavorably impacted by foreign exchange of approximately $13.4 million or 1.8% sequentially and approximately $56.4 million or 7.2% year over year.(1) Q4'22 Imaging Systems and CAD/CAM Services revenues were unfavorably impacted by foreign exchange of approximately $2.7 million or 1.5% sequentially and approximately $11.2 million or 6.2% year over year.(1) Q4'22 operating income was $112.7 million resulting in an operating margin of 12.5%. Q4'22 operating margin was unfavorably impacted by foreign exchange of approximately 0.9 points sequentially and approximately 4.2 points year over year.(1) Q4'22 net income was $41.8 million, or $0.54 per diluted share. On a non-GAAP basis, Q4'22 net income was $134.2 million, or $1.73 per diluted share. (3)

Align Technology Announces Fourth Quarter and Fiscal 2022 Financial Results

Merit Medical Systems

MMSI vs. ALGN: Which Stock Is the Better Value Option?

MMSI or ALGN: Which Is the Better Value Stock Right Now?

Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Align Technology (ALGN) Q4 Earnings Expected to Decline

Alnylam Pharmaceuticals

Bristol-Myers

Royalty Pharma

Teleflex

Universal Health Services

Veeva Systems

Walgreens

Despite inflation making it hard for the healthcare industry to manage its operating costs, there are a few positives that make this sector attractive to investors.

5 Best and Worst Performing Health Care Stocks in December 2022

Catalent

Generac Holdings

Match Group

PayPal

Signature Bank

SVB Financial Group

V.F.

Remember all the beat-up stocks investors wrote off last year? In an interesting twist, last year's worst stocks are turning into the first.

The Market's 10 Worst Stocks Are Now First

Datadog

Not every beaten-down stock from last year is worth buying now, but Align Technology and Datadog are.

Diamonds in the Rough: Which of the Nasdaq 100's Biggest Laggards Are Screaming Buys?

There are plenty of bargains available in the market now.

Is It Time To Buy the S&P 500's 4 Worst-Performing Stocks?

TEMPE, Ariz.--( BUSINESS WIRE )--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2022 financial results on Wednesday, February 1, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com.

Align Technology to Announce Fourth Quarter and 2022 Results on February 1, 2023

This has been the year of reckoning for Big Tech stocks — even those of companies that have continued to grow sales by double digits.

These 20 stocks were the biggest losers of 2022

After brutal declines this year, are these stocks doomed or poised for a rebound?

Down 68% to 73% in 2022, Can the S&P 500's 3 Worst Stocks Recover in 2023?

Roku

Shares of Align and Roku are trading near their 52-week lows.

2 Stocks That Could Look Like Steals in 2023

21 S&P 500 companies have lost at least 50% year-to-date, and the 5 biggest losers on a percentage basis are down more than 65%.

News for Align Technology Stock (ALGN)